- Over 25,000 federal lawsuits were filed against Xarelto manufacturers, Bayer and Johnson & Johnson, claiming that the companies were getting rich from the drug at the expense of putting Americans at risk.
- In March 2019, Bayer and Johnson & Johnson agreed to pay a settlement of $775,000,000.00 to plaintiffs of the state and federal claims.
- If you are one of the thousands of people who have suffered injury after using Xarelto, you may be able to file a claim against Bayer and Johnson & Johnson.
Rivaroxaban, sold under the brand name Xarelto, is an anticoagulant drug that was first developed by Bayer, and is now marketed by Johnson & Johnson’s Janssen pharmaceutical unit. The U.S. Food and Drug Administration approved Xeralto in 2011, and it was prescribed for people with a particular kind of blood clotting called deep vein thrombosis, atrial fibrillation, an irregular heartbeat disorder, and pulmonary embolism.
However, plaintiffs contend that the drug's risks were far greater than its benefits, and the manufacturers marketed it as a better alternative for the drug warfarin. Lawsuits allege that patients were not aware of the dangers of taking the drug, which lead to potentially lethal internal bleeding.How Does Xarelto Work?
Xarelto was one of Johnson & Johnson’s top-selling drugs in 2018, which brought in nearly $2.5 billion in revenue. The drug is used to prevent the formation of blood clots by blocking specific coagulation proteins in the blood. This can reduce the risk of stroke, atrial fibrillation in patients who receive joint replacement surgery, and deep vein thrombosis.
Xarelto was intended to be a safer alternative to warfarin, a decades-old anticoagulant that restricted the patient to a strict diet, frequent dosage adjustments, and numerous blood tests. Bayer and Johnson & Johnson advertised the drug as a part of a group of blood thinners that did not require these measures.
In 2011, the Food and Drug Administration approved the drug to prevent strokes, irregular heart rhythm, and DVT; however, this does not mean that the drug is safe.
Patients who took Xarelto risked uncontrollable bleeding, wound complication, and increased infection rates, particularly after hip or knee joint replacement surgery, and ran the risk of returning to the hospital within 30 days. In cases of emergency trauma or cerebral hemorrhage, bleeding episodes did not respond to standard treatment. For years, there was also no antidote to Xarelto and the other new blood thinners.
In 2018, the Food and Drug Administration approved Andexxa which can help curb uncontrollable bleeding in patients treated with Xarelto. The drug is sold by Pfizer and Bristol-Myers Squibb. Regardless, Bayer and Johnson & Johnson maintained the stance that the drug was safe.Uses of Xarelto
In July 2011, the FDA approved Xarelto to reduce the risk of pulmonary embolism-related blood clots and deep vein thrombosis that can develop after joint replacement surgeries. By the end of the year, the drug was also approved to treat patients who suffered from irregular heart rhythms.
By 2012, the federal agency expanded the use of Xarelto to treat patients with pulmonary embolism and deep vein thrombosis even if the patient had not undergone hip or knee replacement surgeries.
The ISPM reported that researchers have found over 350 cases of severe debilitating injuries, and even deaths, associated with Xarelto in the first quarter of 2012. The report included over 120 injuries resulting from hemorrhages, and over 150 injuries associated with blood clots, some involving pulmonary embolism. The latter side effects were the most disturbing since the drug has been designed to decrease the risk of PE-related blood clots. Most of these injuries happened in people averaging the age of 66, which is much younger than expected.
After this revelation, the ISMP reported their concerns to Janssen Pharmaceutical and said that they believed that Xarelto was “the most frequent suspect drug and serious and fatal adverse events in 2012.” However, the company neglected to address the issue.
In 2013, Johnson & Johnson was ordered to add further details to their safety labeling to warn patients that stopping the use of Xarelto prematurely could increase the risk of blood clots and thrombosis. Then, in 2014, the federal regulatory authorities added another label to Xarelto informing that the antibiotic drug, erythromycin, did not work well with rivaroxaban in patients suffering from kidney disorders. The FDA warned that these people might risk internal bleeding if the drugs were taken together.Related Medical Conditions of Xarelto
Xarelto was associated with severe side effects that not just lead to injuries but also death. Some include:
- Severe internal bleeding and hemorrhaging that did not respond to conventional treatments.
- Pulmonary embolism
- Abnormal liver function
- Bleeding in the lungs, intestine, stomach, and vagina
- Retinal bleeding
- Cerebral hemorrhaging
- Blockage of normal bile flow
- Coughing up blood
- Wound complications and increased risk of infection
- Deep vein thrombosis
- Hematoma or spinal epidural tissue swelling
- Bleeding gums and mouth irritation
- Bloody stools
- Excessive blood loss
- Fainting spells
- Reduction in platelets
- Urinary tract infection
- Development of giant hives
- Dizziness and headaches
- Vomiting blood
- Back pain
- Sinus congestion
- Several allergic reactions
- Muscle spasms
- Hepatitis and jaundice
- Difficulty swallowing
- Breathing difficulties
- Dysfunction of the bladder
- Paralysis on one side of the body
- Steven-Johnson’s syndrome, a rare but potentially lethal disorder of the skin and mucous membrane
After Xarelto’s release in 2011, the first lawsuit against the drug came in 2014 in Pennsylvania. Virginia Stunteneck of Kentucky started taking Xarelto in July 2012 because of her atrial fibrillation. In February 2013, less than a year after she started taking the drug, Stunteneck started experiencing gastrointestinal bleeding which required emergency medical intervention and hospitalization.
Then in May, Della Wise filed a lawsuit on behalf of her aunt, Mattie Edgin, who died after she took Xarelto. The plaintiff claimed wrongful death through fraud, consumer law violation, product liability, failure to warn, negligence, breach of warranty, and false marketing of a dangerous drug.
In June, Nancy Packard, the widow of William Packard Jr., filed a Xeralto lawsuit alleging that her husband died due to uncontrollable bleeding after he began taking Xarelto in January 2012 for atrial fibrillation. Less than six months later, Packard developed a brain hemorrhage because of the drug and was hospitalized. Unfortunately, the doctors were unable to stop the bleeding, and Packard passed away.
In July, Ruth McGowan of Vermont also filed a wrongful death claim on behalf of her father, Thomas Dunkley, who died after taking Xarelto for just ten days. Dunkley developed a hemorrhagic stroke that resulted in his death.
In the same month, Jeanne Jeffcoat filed her federal lawsuit claiming she took Xarelto from March to July 2012 to decrease her chances of having a stroke, and ended up with life-threatening bleeding that required a prolonged treatment in a hospital and left her permanently injured.
In 2013, Harry and Joseph Griggs filed a wrongful death suit on behalf of their father, Charles Griggs, who died from severe bleeding after taking the drug. The bleeding resulted in severe injuries that caused the victim’s death in December of the same year.
Subsequently, INRation, a medical device that was used in a clinical trial for Xarelto, was recalled by Alere Inc., its manufacturer. Plaintiffs in many of the lawsuits alleged that the device did not work right and provided readings that made it seem like Xeralto was safer and more effective than warfarin. Their personal injury lawyers claimed that Bayer and Johnson & Johnson exercised recklessness in their haste to bring Xarelto to the market.
In December 2017, a Philadelphia state jury ordered Bayer and Johnson & Johnson to pay a settlement in excess of $27 million to Lynn Hartman of Indiana, who suffered from GIT bleeding after using Xarelto for a year. However, the trial judge later overturned the verdict, and Hartman's attorney reported the new ruling was based on a narrow issue involving Hartman's doctor.How Many Lawsuits Have Been Filed Against Xeralto Manufacturer?
Thousands of patients alleged that they had been seriously hurt by Xarelto and filed lawsuits against Bayer and Johnson & Johnson, demanding compensation for the damage. Others claimed their loved ones suffered permanent injuries and even died after taking the blood thinner.
In all, over 25,000 federal lawsuits were filed against the drug manufacturers claiming that the companies were getting rich from the drug at the expense of putting Americans at risk. Bayer earned over $4 billion, and Johnson & Johnson earned $2.47 billion for Xarelto in just 2018.
Lawsuits also said the drug created complications after surgery, developing infections, leaks, and other issues in the surgical site.
In March 2019, Bayer and Johnson & Johnson agreed to pay a sum of $775,000,000 to the plaintiffs of the state and federal claims. The settlement amount was split equally between the two companies. However, despite agreeing to pay the settlement, the two drug manufacturers refused to admit liability for Xarelto, and said the claims made by the plaintiffs lacked any merit. Bayer said in a statement that they agreed to pay the settlement to avoid the distraction and cost of dragging the case.Who Can File a Claim for Xarelto Lawsuit?
Thousands of other injured patients have already filed Xarelto lawsuits against Bayer and Johnson & Johnson, claiming that their injuries were due to the dangerous side effects of the drug. Similarly, if you have been harmed by Xeralto, or if you have lost any of your loved ones to this dangerous drug, you may be eligible to file a Xeralto lawsuit to seek compensation for damages.
You may be able to file a suit against the drug manufacturers if Xarelto was prescribed and resulted in injuries, including unstoppable bleeding, stroke, or other serious events. You may be eligible to bring a wrongful death suit if your loved one passed away after taking Xarelto.How Long Do I Have to File A Xarelto Lawsuit?
If you or your loved one has been harmed while taking Xarelto, it is important that you file a case before the state or federal statute of limitations expires. The Statute of Limitations will vary from state to state. If you fail to file your lawsuit within the Statute of Limitations, your lawsuit will likely be dismissed and your claim will be forever barred.
If you think you have a case, contact Frankl & Kominsky to discuss your legal options. We will review your case and try to determine whether you are eligible to receive compensation for damages.Hire an Injury Lawyer to File a Xarelto Rivaroxaban Lawsuit
Our injury lawyers at Frankl & Kominsky understand that the pain and injury you suffered through were not because of a fault of your own, but the responsibility of Bayer and Johnson & Johnson, who falsely marketed and sold the drug for profit at the expense of many lives. Our personal injury lawyers have obtained over $75 million on behalf of victims in accident and injury settlements to address that they are appropriately covered for their medical expenses, lost wages, pain, mental trauma, and emotional damage.
Frankl & Kominsky lawyers, working on behalf of the plaintiffs will try to investigate your claim. Some of the factors that will be taken into consideration include:
- The extent of the damage suffered by the victim who was prescribed Xarelto
- The duration of the injuries and hospitalization
- The effect that the injuries had on the victim’s physical and mental conditions
- The current condition of the victim who was prescribed Xarelto
- The amount of pain, suffering, mental anguish, and emotional trauma the victim suffered in the past and might suffer going forward.
- The extent of the damages to the victim, including the past, present, and future medical bills, lost wages, and in case of wrongful death, funeral expenses.
The Frankl & Kominsky legal team encourages you to contact them today at 855-800-8000 to schedule a no-obligation free consultation visit to discuss the possible merits of your claim. We are available to accept all sorts of personal injury cases, product liability and bad drug injury claims, and wrongful death claims through contingency fee arrangements. If we are unable to get you financial compensation for your case, you do not owe us anything. We provide full confidentiality to all our clients.